Treatment of recent facial nerve damage with lagophthalmos, using a semistandardized steroid regimen
| Autor: | K U Kiran, S Suneetha, Hogeweg M |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Chemotherapy
medicine.medical_specialty Borderline leprosy Lagophthalmos medicine.drug_class business.industry Eye disease medicine.medical_treatment Prednisolone General Medicine medicine.disease Facial nerve Steroid Surgery Leprosy Lepromatous Regimen medicine Eyelid Diseases Corticosteroid Humans Leprosy Borderline Facial Nerve Diseases business Skin |
| Zdroj: | Leprosy review. 62(2) |
| ISSN: | 0305-7518 |
| Popis: | Twenty-seven patients with borderline leprosy and facial nerve damage of less than or equal to 6 months duration (36 eyes) were treated with a semistandardized regimen of steroids (the average starting dose was 25-30 mg, duration 5-6 months) on an outpatient basis. Red and raised reactive patches were usually present in the upper malar area or around the eye(s) in patients with recent lagophthalmos. The lid gap was measured in millimetres during gentle and strong closure. After completion of the steroid course 75% of the eyes had complete closure or only a slight gap of less than or equal to 2 mm on gentle closure. Steroids were found to be beneficial and safe, in the dosage that we prescribed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|